Chung Wu Investment Group, LLC
Position in PVLA — Palvella Therapeutics, Inc.
CIK 2054278
SUGAR LAND, TX
Position in PVLA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$286,695
+$14,553 QoQ
Shares Held
2,300
-11.5% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Common Shares in PVLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Chung Wu Investment Group, LLC holds $892,086 across 11 Biotechnology names. PVLA ranks #1 (32.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PVLA |
Palvella Therapeutics, Inc.
This page
|
2,300 | $286,695 | |
| 2 | SRRK |
Scholar Rock Holding Corp
|
4,200 | $206,472 | |
| 3 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
2,300 | $193,016 | |
| 4 | TYRA |
Tyra Biosciences, Inc.
|
2,000 | $76,600 | |
| 5 | DYN |
Dyne Therapeutics, Inc.
|
2,000 | $36,260 | |
| 6 | VIR |
Vir Biotechnology, Inc.
|
3,410 | $30,553 | |
| 7 | TRVI |
Trevi Therapeutics, Inc.
|
2,000 | $23,860 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
30 | $23,179 |
All Filings in PVLA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $286,695 | 2,300 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $272,142 | 2,600 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $12,538 | 200 | Shares | Sole | 2025-11-04 | |
| No filing history on record for this holder in this stock. | ||||||